Trends and Factors Associated with Nebulized Therapy Prescription in Older Adults with Chronic Obstructive Pulmonary Disease from 2008 to 2015

Keyphrases

• Older Adults 100%
• Chronic Obstructive Pulmonary Disease 100%
• Odds Ratio 100%
• Confidence Interval 100%
• Nebulized Therapy 100%
• Therapy Prescription 100%
• Nebulised Drugs 85%
• Medicare Beneficiaries 42%
• Short-acting 28%
• Muscarinic Agents 28%
• Short-acting beta-agonist 28%
• Reliever 28%
• Corticosteroids 14%
• Fee-for-service 14%
• Drug Delivery 14%
• Inhalational 14%
• Hospitalization 14%
• Limited Information 14%
• Inhaled Corticosteroids 14%
• Medical Management 14%
• Patient Management 14%
• Medicare Population 14%
• Female Gender 14%
• Dual Eligibility 14%
• Retrospective Longitudinal Study 14%
• Home Oxygen Therapy 14%
• Respiratory Stimulant 14%
• Low-income Subsidy 14%
• Long-acting beta-agonists 14%
• Nebulizer 14%
• Inhaler 14%
• Long-acting Bronchodilators 14%
• Specialist Visits 14%
• Pulmonary Specialist 14%
• Long-acting muscarinic Antagonist 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Obstructive Lung Disease 100%
• Beta Adrenergic Receptor Stimulating Agent 42%
• Muscarinic Agent 42%
• Cross-Sectional Study 14%
• Bronchodilating Agent 14%
• Nebulizer 14%